The effect of functional insulin therapy on glycaemic parameters in children with diabetes mellitus type 1

Diana Štimjanin-Koldžo1, Salem Alajbegović2, Ena Štimjanin2

  • 1Department of Paediatrics, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina.

Insights

A 5-day education program improved type 1 diabetes management, significantly reducing HbA1c and insulin doses. However, motivation waned after a year, highlighting the need for ongoing education to maintain glycaemic control.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Diabetes Management

Background:

  • Type 1 diabetes requires continuous management and education for patients and families.
  • The Düsseldorf model offers a structured approach to diabetes education.

Purpose of the Study:

  • To assess the impact of a 5-day interactive education program on type 1 diabetes management.
  • To evaluate changes in glycated haemoglobin (HbA1c) and insulin dosage.
  • To determine the long-term effectiveness of the educational intervention.

Main Methods:

  • A prospective study involving 67 type 1 diabetes patients (mean age 11 years).
  • A 5-day education program led by diabetes specialists.
  • Assessment of patient and parent knowledge, HbA1c, and total daily insulin dose at baseline and follow-up points (3, 6, 9, 12 months).

Main Results:

  • Significant reduction in total daily insulin dose post-program.
  • HbA1c decreased by 3.17% at 9 months and 1.8% at 12 months compared to baseline (p<0.001).
  • Knowledge scores improved, but glycaemic control declined after 12 months due to decreased motivation.

Conclusions:

  • Structured education on functional insulin therapy improves glycaemic control in type 1 diabetes.
  • Patient and parental motivation are key to sustained glycaemic control.
  • Yearly re-education is necessary to maintain long-term benefits and combat declining motivation.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
941
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.5K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
872